imaware™, a leader in at-home health testing, is partnering with VirtualPractices.org to offer at-home COVID Antibody testing. This testing is available through an at-home kit that will be sent directly to your or your patients' home with easy-to-follow collection steps. The price for this test is $119.
Sign up below to learn more about how we can help you provide remote testing & monitoring for your patients. We’re offering access to our digital platform completely free for all practitioners that are part of this initiative.
This test is for people who want to detect if they’ve been exposed to the COVID-19 virus. This test may be right for you if you are asymptomatic and have not experienced symptoms consistent with COVID-19 in the past 10 days. It is not intended to diagnose someone who is currently sick with COVID-19
The imaware™ home collection kit is easy to use, painless and requires only 3-5 drops of blood. You’ll receive the kit in the mail, draw your sample and send it back to our partnered labs using the provided package. Your results will be sent to you within 5 days over email.
This test is currently available everywhere in the United States except for New York.
You must be 18 years of age or older to order this test
Sign up for free on this site and receive a sample report
A specialist from our team will reach out to help personalize your imaware™ experience and answer your questions
Gain access to your healthcare practitioner's portal and begin testing your patients
Watch how the test arrives and how to properly collect a sample.
Use the pain-free lancet by pressing it against the tip of your finger and press the button.
Collect the drops of blood from your finger into the collection device.
Secure your sample, and mailing it back to us with the provided return label
Your results are available online for review within 5 days
Our CLIA-certified national lab provider offers The SARS-CoV-2 (COVID-19) test that uses the FDA Emergency Use Authorization (EUA) approved CDC 2019-Novel Coronavirus (2019-nCoV) Real-Time Reverse Transcriptase (RT)-PCR Diagnostic Panel, that’s intended for the detection of COVID-19 in individuals who meet CDC or public health criteria for COVID-19 testing.
It's important to note that:
1) This test has not been FDA cleared or approved
2) This test has been authorized by FDA under an EUA for use by authorized laboratories;
3) This test has been authorized only for the detection of nucleic acid from 2019-nCoV, not for any other viruses or pathogens, and;
4) This test is only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostic tests for detection and/or diagnosis of SARS-CoV-2 under Section 564(b)(1) of the Act, 21 U.S.C. § 360bbb-3(b)(1), unless the authorization is terminated or revoked sooner.
imaware™’s testing for COVID-19 is administered with a swab that is inserted into the nostril to reach the nasopharyngeal region, from where cells are collected -- a process that can make self-collection difficult. A healthcare professional is sent to the patient’s home to administer the test, deliver the sample to the lab and return accurate, easy-to-understand results. An independent telemedicine clinician under the Wheel network reviews the results and reaches out to patients testing positive for the virus with care instructions.
The imaware™ remote screening and testing solution is $135. Patients pay the fee online at checkout, prior to requesting an at-home sample collection. All fees include the screening, on-site testing by a healthcare professional, sample processing, results and follow up by an independent telemedicine clinician if needed.
Many municipalities, like Houston, are offering free drive through testing to meet the needs of the low-medium risk population. imaware™ is specifically intended for vulnerable, high-risk individuals. As of now, private testing is not being subsidized by the federal or state government. We are providing this solution at cost
Patients can expect test results back within 72 hours after a healthcare professional collects their test sample.
The imaware™ test is set apart from other at-home options by the lower margin for error, due to the test being administered by a healthcare professional. While other types of tests requiring blood or saliva samples are simpler to self-collect, self-collected COVID-19 swab tests are at a greater risk for inaccurate results.
imaware™ adds patient-centric care to the equation post diagnosis through its superior telemedicine consult, Wheel, to help patients navigate symptoms through to recovery.
Read more about our thoughts on healthcare, how early screening can benefit you and other amazing imaware™ stories